Month: November 2016
-
Long-Acting Opioid Abuse Therapy Shown Working in Trial
An experimental long-acting drug was shown at least as effective, and in some cases superior, to the current standard of care for opioid use disorder.
-
Electronic Pulses Shown to Induce Cancer Immune Response
A medical device company presented results of preclinical studies showing its drug-free electronic pulse technology encourages the immune system to kill and clear cancer cells.
-
Seedless Fruit Varieties Seen As Food Security Boost
A review of studies evaluating techniques for producing seedless fruit concludes these techniques can contribute to higher yields that help ensure the security of food supplies.
-
Small-Business Grants Awarded for Neurological Diseases
A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
Liquid Biopsy Lab to Reside at Cancer Institute
A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California.
-
Florida Voters Give Split Decision on GM Mosquitoes [Updated]
Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus.
-
Phone-Based Microscope Developed for Water Testing
An engineering lab at University of Houston in Texas designed an inexpensive lens that when placed over a smartphone’s camera, turns the phone into a microscope.
-
RNA Drug Delivery Technique Shown Safe in Monkeys
A biotechnology company reports a drug delivery method combining nanoscale lipid particles and biocompatible polymers enables the safe production of synthetic RNA-based proteins in monkeys.
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.